Autolus Therapeutics plc
AUTL
$2.12
-$0.11-4.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.94% | 14.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.94% | 14.60% | |||
| Cost of Revenue | -15.68% | -3.97% | |||
| Gross Profit | 34.80% | 15.12% | |||
| SG&A Expenses | -5.15% | 16.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.08% | 3.87% | |||
| Operating Income | 17.48% | -0.70% | |||
| Income Before Tax | 22.71% | -16.45% | |||
| Income Tax Expenses | 172.95% | -322.37% | |||
| Earnings from Continuing Operations | 20.74% | -14.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.74% | -14.17% | |||
| EBIT | 17.48% | -0.70% | |||
| EBITDA | 18.24% | -0.59% | |||
| EPS Basic | 20.74% | -14.16% | |||
| Normalized Basic EPS | 22.42% | -16.04% | |||
| EPS Diluted | 20.74% | -14.16% | |||
| Normalized Diluted EPS | 22.42% | -16.04% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||